These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 11982460)
1. Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent. Ramasubbu R Arch Gen Psychiatry; 2002 May; 59(5):472; author reply 472-3. PubMed ID: 11982460 [No Abstract] [Full Text] [Related]
2. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469 [TBL] [Abstract][Full Text] [Related]
3. A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone. Yamauchi K; Ohta K; Taniguchi T; Ohmori T Gen Hosp Psychiatry; 2004; 26(3):242-3. PubMed ID: 15121355 [No Abstract] [Full Text] [Related]
4. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study. Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781 [TBL] [Abstract][Full Text] [Related]
5. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. Agid O; Lerer B J Clin Psychiatry; 1999 Jan; 60(1):55-6. PubMed ID: 10074882 [No Abstract] [Full Text] [Related]
6. Possible dose-response relationship for risperidone in obsessive-compulsive disorder. Baker RW J Clin Psychiatry; 1998 Mar; 59(3):134. PubMed ID: 9541161 [No Abstract] [Full Text] [Related]
11. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Hollander E; Baldini Rossi N; Sood E; Pallanti S Int J Neuropsychopharmacol; 2003 Dec; 6(4):397-401. PubMed ID: 14604454 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors]. Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387 [TBL] [Abstract][Full Text] [Related]
13. Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases. Sun TF; Lin PY; Wu CK Chang Gung Med J; 2001 Sep; 24(9):587-92. PubMed ID: 11725630 [TBL] [Abstract][Full Text] [Related]
14. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. Stein DJ; Bouwer C; Hawkridge S; Emsley RA J Clin Psychiatry; 1997 Mar; 58(3):119-22. PubMed ID: 9108814 [TBL] [Abstract][Full Text] [Related]
15. Augmenting obsessive-compulsive disorder treatment: from brain to mind. Ressler KJ; Rothbaum BO JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506 [No Abstract] [Full Text] [Related]
16. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Ramasubbu R; Ravindran A; Lapierre Y Pharmacopsychiatry; 2000 Nov; 33(6):236-8. PubMed ID: 11147933 [TBL] [Abstract][Full Text] [Related]